Table 1 Demographic and laboratory data of the patients
From: MicroRNA 21as a novel biomarker in hepatitis C virus-related hepatocellular carcinoma
Parameter | Group 1: Patients with liver cirrhosis (mean ± SD) | Group 2: Patients with liver cirrhosis and HCC group (mean ± SD) | P value |
|---|---|---|---|
Age (year) | 63.44 ± 9 | 61 ± 7.76 | 0.472 |
Platelets (/cmm) | 95.8 × 103 ± 38.5 | 148.40 × 103± 55.24 | 0.001 |
Haemoglobin (g/dl) | 9.62± 1.58 | 10.4 ± 1.42 | 0.053 |
Albumin (mg/dl) | 2.52 ± 0.62 | 2.57 ± 0.61 | 0.719 |
ALT (U/ml) | 35.08 ± 25.37 | 81.28 ± 72.27 | < 0.001 |
AST (U/ml) | 59.24 ± 31.36 | 138.20 ± 93.02 | < 0.001 |
GGT (U/ml) | 48.56 ± 45.48 | 155.44 ± 159.04 | 0.001 |
Total bilirubin (mg/dl) | 1.98 ± 2.79 | 3.91 ± 4.20 | 0.004 |
Direct BIL. (mg/dl) | 0.89 ± 1.72 | 1.84 ± 1.88 | 0.004 |
Prothrombin time (second) | 17.15 ± 3.49 | 16.17 ± 2.21 | 0.392 |
INR | 1.53 ± 0.40 | 1.50 ± 0.36 | 0.923 |
Alfa feto protein (AFP) | 5.77 ± 6.08 | 4762.32 ± 13800.58 | < 0.001 |
miRNA | 5.04 ± 2.11 | 8.28 ± 2.55 | < 0.001 |